MATSUDA MASARU (SVP and General Counsel) sold 6.1% of their position (8.26K shares) of ARCUTIS BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $192.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/6/2026ACC: 0001798679-26-000002
Officer· SVP and General Counsel
Since Jan 2022
-8.26K
Net shares
Net seller
$192.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
8.26K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.37K
Price / share
$23.27
Trade value
$171.54K
% of position
5.5%
5/4/2026
134.94K→127.57K
Common Stock
Direct
Shares
−884.00
Price / share
$23.61
Trade value
$20.87K
% of position
0.7%
5/4/2026
127.57K→126.69K
Total
Net shares
−8.26K
Net value
-$192.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/4/2026 | S · Sale | −7.37K | $23.27 | $171.54K | 5.5% | 134.94K | 127.57K |
| Common Stock Direct | 5/4/2026 | S · Sale | −884.00 | $23.61 | $20.87K | 0.7% | 127.57K | 126.69K |
| Total | −8.26K | -$192.42K | ||||||
Derivative Transactions0
No derivative transactions reported